HLA-E and viral infectious disease: Interactions between the HLA‐E VL9 complex and NKG2A receptor exert an inhibitory effect on NK cells, and thus, when VL9 peptide supply is limited, such as in viral infection, where HLA class I is downregulated, this loss of signal releases NK cells from inhibition [5].